Importantly, HCC is a hypervascularized tumor [97] and ALK1 expression in liver tumor blood vessels has been shown to be high [93], facts that make HCC a good candidate for ALK1 inhibition therapeutic strategy. The gene discussed is ALK; the disease is neoplasm.